Brain Metabolic Profile after Intranasal vs. Intraperitoneal Clomipramine Treatment in Rats with Ultrasound Model of Depression

Background: Molecular mechanisms of depression remain unclear. The brain metabolome after antidepressant therapy is poorly understood and had not been performed for different routes of drug administration before the present study. Rats were exposed to chronic ultrasound stress and treated with intra...

Full description

Bibliographic Details
Main Authors: Olga Abramova, Yana Zorkina, Timur Syunyakov, Eugene Zubkov, Valeria Ushakova, Artemiy Silantyev, Kristina Soloveva, Olga Gurina, Alexander Majouga, Anna Morozova, Vladimir Chekhonin
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/22/17/9598
id doaj-be54e2709d314978a1f0ddc622ef38d1
record_format Article
spelling doaj-be54e2709d314978a1f0ddc622ef38d12021-09-09T13:48:46ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-09-01229598959810.3390/ijms22179598Brain Metabolic Profile after Intranasal vs. Intraperitoneal Clomipramine Treatment in Rats with Ultrasound Model of DepressionOlga Abramova0Yana Zorkina1Timur Syunyakov2Eugene Zubkov3Valeria Ushakova4Artemiy Silantyev5Kristina Soloveva6Olga Gurina7Alexander Majouga8Anna Morozova9Vladimir Chekhonin10V. Serbsky National Medical Research Centre of Psychiatry and Narcology, 119034 Moscow, RussiaV. Serbsky National Medical Research Centre of Psychiatry and Narcology, 119034 Moscow, RussiaMental-Health Clinic No. 1 Named after N.A. Alekseev, 117152 Moscow, RussiaV. Serbsky National Medical Research Centre of Psychiatry and Narcology, 119034 Moscow, RussiaV. Serbsky National Medical Research Centre of Psychiatry and Narcology, 119034 Moscow, RussiaV. Serbsky National Medical Research Centre of Psychiatry and Narcology, 119034 Moscow, RussiaMental-Health Clinic No. 1 Named after N.A. Alekseev, 117152 Moscow, RussiaV. Serbsky National Medical Research Centre of Psychiatry and Narcology, 119034 Moscow, RussiaDrug Delivery Systems Laboratory, D. Mendeleev University of Chemical Technology of Russia, Miusskaya pl. 9, 125047 Moscow, RussiaV. Serbsky National Medical Research Centre of Psychiatry and Narcology, 119034 Moscow, RussiaV. Serbsky National Medical Research Centre of Psychiatry and Narcology, 119034 Moscow, RussiaBackground: Molecular mechanisms of depression remain unclear. The brain metabolome after antidepressant therapy is poorly understood and had not been performed for different routes of drug administration before the present study. Rats were exposed to chronic ultrasound stress and treated with intranasal and intraperitoneal clomipramine. We then analyzed 28 metabolites in the frontal cortex and hippocampus. Methods: Rats’ behavior was identified in such tests: social interaction, sucrose preference, forced swim, and Morris water maze. Metabolic analysis was performed with liquid chromatography. Results: After ultrasound stress pronounced depressive-like behavior, clomipramine had an equally antidepressant effect after intranasal and intraperitoneal administration on behavior. Ultrasound stress contributed to changes of the metabolomic pathways associated with pathophysiology of depression. Clomipramine affected global metabolome in frontal cortex and hippocampus in a different way that depended on the route of administration. Intranasal route was associated with more significant changes of metabolites composition in the frontal cortex compared to the control and ultrasound groups while the intraperitoneal route corresponded with more profound changes in hippocampal metabolome compared to other groups. Since far metabolic processes in the brain can change in many ways depending on different routes of administration, the antidepressant therapy should also be evaluated from this point of view.https://www.mdpi.com/1422-0067/22/17/9598metabolomeratsdepressive-like behaviorhippocampusfrontal cortex
collection DOAJ
language English
format Article
sources DOAJ
author Olga Abramova
Yana Zorkina
Timur Syunyakov
Eugene Zubkov
Valeria Ushakova
Artemiy Silantyev
Kristina Soloveva
Olga Gurina
Alexander Majouga
Anna Morozova
Vladimir Chekhonin
spellingShingle Olga Abramova
Yana Zorkina
Timur Syunyakov
Eugene Zubkov
Valeria Ushakova
Artemiy Silantyev
Kristina Soloveva
Olga Gurina
Alexander Majouga
Anna Morozova
Vladimir Chekhonin
Brain Metabolic Profile after Intranasal vs. Intraperitoneal Clomipramine Treatment in Rats with Ultrasound Model of Depression
International Journal of Molecular Sciences
metabolome
rats
depressive-like behavior
hippocampus
frontal cortex
author_facet Olga Abramova
Yana Zorkina
Timur Syunyakov
Eugene Zubkov
Valeria Ushakova
Artemiy Silantyev
Kristina Soloveva
Olga Gurina
Alexander Majouga
Anna Morozova
Vladimir Chekhonin
author_sort Olga Abramova
title Brain Metabolic Profile after Intranasal vs. Intraperitoneal Clomipramine Treatment in Rats with Ultrasound Model of Depression
title_short Brain Metabolic Profile after Intranasal vs. Intraperitoneal Clomipramine Treatment in Rats with Ultrasound Model of Depression
title_full Brain Metabolic Profile after Intranasal vs. Intraperitoneal Clomipramine Treatment in Rats with Ultrasound Model of Depression
title_fullStr Brain Metabolic Profile after Intranasal vs. Intraperitoneal Clomipramine Treatment in Rats with Ultrasound Model of Depression
title_full_unstemmed Brain Metabolic Profile after Intranasal vs. Intraperitoneal Clomipramine Treatment in Rats with Ultrasound Model of Depression
title_sort brain metabolic profile after intranasal vs. intraperitoneal clomipramine treatment in rats with ultrasound model of depression
publisher MDPI AG
series International Journal of Molecular Sciences
issn 1661-6596
1422-0067
publishDate 2021-09-01
description Background: Molecular mechanisms of depression remain unclear. The brain metabolome after antidepressant therapy is poorly understood and had not been performed for different routes of drug administration before the present study. Rats were exposed to chronic ultrasound stress and treated with intranasal and intraperitoneal clomipramine. We then analyzed 28 metabolites in the frontal cortex and hippocampus. Methods: Rats’ behavior was identified in such tests: social interaction, sucrose preference, forced swim, and Morris water maze. Metabolic analysis was performed with liquid chromatography. Results: After ultrasound stress pronounced depressive-like behavior, clomipramine had an equally antidepressant effect after intranasal and intraperitoneal administration on behavior. Ultrasound stress contributed to changes of the metabolomic pathways associated with pathophysiology of depression. Clomipramine affected global metabolome in frontal cortex and hippocampus in a different way that depended on the route of administration. Intranasal route was associated with more significant changes of metabolites composition in the frontal cortex compared to the control and ultrasound groups while the intraperitoneal route corresponded with more profound changes in hippocampal metabolome compared to other groups. Since far metabolic processes in the brain can change in many ways depending on different routes of administration, the antidepressant therapy should also be evaluated from this point of view.
topic metabolome
rats
depressive-like behavior
hippocampus
frontal cortex
url https://www.mdpi.com/1422-0067/22/17/9598
work_keys_str_mv AT olgaabramova brainmetabolicprofileafterintranasalvsintraperitonealclomipraminetreatmentinratswithultrasoundmodelofdepression
AT yanazorkina brainmetabolicprofileafterintranasalvsintraperitonealclomipraminetreatmentinratswithultrasoundmodelofdepression
AT timursyunyakov brainmetabolicprofileafterintranasalvsintraperitonealclomipraminetreatmentinratswithultrasoundmodelofdepression
AT eugenezubkov brainmetabolicprofileafterintranasalvsintraperitonealclomipraminetreatmentinratswithultrasoundmodelofdepression
AT valeriaushakova brainmetabolicprofileafterintranasalvsintraperitonealclomipraminetreatmentinratswithultrasoundmodelofdepression
AT artemiysilantyev brainmetabolicprofileafterintranasalvsintraperitonealclomipraminetreatmentinratswithultrasoundmodelofdepression
AT kristinasoloveva brainmetabolicprofileafterintranasalvsintraperitonealclomipraminetreatmentinratswithultrasoundmodelofdepression
AT olgagurina brainmetabolicprofileafterintranasalvsintraperitonealclomipraminetreatmentinratswithultrasoundmodelofdepression
AT alexandermajouga brainmetabolicprofileafterintranasalvsintraperitonealclomipraminetreatmentinratswithultrasoundmodelofdepression
AT annamorozova brainmetabolicprofileafterintranasalvsintraperitonealclomipraminetreatmentinratswithultrasoundmodelofdepression
AT vladimirchekhonin brainmetabolicprofileafterintranasalvsintraperitonealclomipraminetreatmentinratswithultrasoundmodelofdepression
_version_ 1717760110789394432